Clinical trial Recruiting at 1 site Observational Ages 18 to 39

Impact of COVID-19 on young cancer patients and survivors

Official title: Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult (AYA) Cancer Patients and Survivors

Run by M.D. Anderson Cancer Center · NCT04551378 · Data updated 2026-11-12

This study is trying to see how the COVID-19 pandemic has affected the mental, physical, and social well-being of young cancer patients and survivors aged 18 to 39.

More Malignant Solid Neoplasm trials

Quick facts

Study typeObservational
Ages18 Years to 39 Years
SexAll
Enrollment600 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedJuly 13, 2020
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedNovember 10, 2026
Trial IDNCT04551378 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are AYA cancer patients and survivors aged 18 to 39 who were diagnosed between the ages of 15 to 39 and have received treatment at MD Anderson Cancer Center.

Probably not a fit

Patients who are unable to complete questionnaires in English or those who visited MD Anderson for non-treatment related reasons may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines how the COVID-19 pandemic has affected the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. Participants, aged 18 to 39 who were diagnosed with cancer between 15 to 39 years old, will complete an online survey assessing their COVID-19 specific psychological distress, healthcare utilization, health behaviors, and quality of life. The study aims to identify associations between demographic factors and resilience with these outcomes, and may lead to targeted interventions to improve the well-being of this vulnerable population.

Why it matters

Potential benefit: If successful, this study could lead to improved psychosocial health interventions for AYA cancer patients and survivors affected by the pandemic.

How similar studies have gone: While the specific focus on AYA cancer patients during the COVID-19 pandemic is novel, similar studies have shown success in understanding the psychosocial impacts of health crises on vulnerable populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* PATIENT COHORT INCLUSION:
* Initial cancer diagnosis between the ages of 15 to 39
* Received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry
* For questionnaire provision: confirmed alive at time of contact

Exclusion Criteria:

* PATIENT COHORT EXCLUSION:
* Inability to complete questionnaires in English
* Seen at MD Anderson for a second opinion or non-treatment related visit

Where it's running

  • M D Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.